Results 1 - 5 of 12 for: "iodoquinol systemic"
Refine your search:

Hivid
...0.04 mg/kg Hivid administered orally every 6 hours.1 The mean bioavailability of zalcitabine in these pediatric patients was 54% and mean apparent systemic clearance was 150 mL/min/m2. Due to the small number of subjects and different analytical techniques, it is difficult to make comparisons between...
Professional Monographs (FDA) · More like this · Add to my drug list

Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
...This transaction should be neutral to Galderma's net income in 2008 and accretive as of 2009.' CollaGenex launched Oracea(R), the first FDA-approved systemic product indicated for the treatment of rosacea, in July 2006. CollaGenex is also developing Col-118, an innovative product for the treatment of...
News & Articles (Drugs.com) · More like this

Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
...for the treatment of rosacea. This report has concluded these studies establish the first important body of evidence supporting the use of a systemic therapy for rosacea that is devoid of antibiotic activity. The study further concludes that 'the antibacterial effects of doxycycline or other...
Clinical Trial Results (FDA) · More like this

Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
...of 141% over 2006 sales of $26.4 million, driven by the acceptance of Oracea(R). In July 2006, CollaGenex launched Oracea(R), the first FDA-approved systemic product for the treatment of rosacea. CollaGenex's professional dermatology sales force also markets Alcortin(R) (1% iodoquinol and 2% hydrocortisone),...
News & Articles (Drugs.com) · More like this

CollaGenex Pharmaceuticals Announces Results of Phase 4 Clinical Study Showing Oracea Equally Effective as 100 mg Doxycycline in Treatment of Rosacea
...marketing proprietary, innovative medical therapies to the dermatology market. In July 2006, CollaGenex launched Oracea(R), the first FDA-approved systemic product for the treatment of rosacea. CollaGenex's professional dermatology sales force also markets Alcortin(R) (1% iodoquinol and 2% hydrocortisone),...
Clinical Trial Results (FDA) · More like this

Having trouble finding what you want?


MedNotes
Advertisement

(web2)